Saved source record
The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease.
This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.
Source status: Exact-ID Europe PMC status checked Sep 25, 2026. No retraction or correction publication-type marker was listed in that response. This does not rule out other updates.
Study metadata
- Study type
- Original study
- Study category (metadata hint)
- Animal
- Published
- 2025-10-01
- Authors
- Radchenko AI, Kuzubova EV, Apostol AA, Mitkevich VA, Andreeva LA, Limborska SA, Stepenko YV, Shmigerova VS
- Journal or registry
- Not reported
- Registry study design
- Not reported
- Registry enrollment
- Not reported
- Funding agencies
- Not reported in source metadata
- Identifiers
- DOI: 10.32607/actanaturae.27808 · PMID: 41479572 · PMCID: PMC12755871
- First found
- Sep 24, 2026
- Last found
- Sep 25, 2026
Original sources
Browse saved studies · Search live sources